BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8926012)

  • 1. Serum immunoglobulin E and soluble CD23 in patients with Graves' disease.
    Sayinalp S; Akalin S; Sayinalp N; Erbaş T; Bayraktar M; Ozcebe OI; Dündar S; Kirazli S
    Horm Metab Res; 1996 Mar; 28(3):133-7. PubMed ID: 8926012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I; Horváth S; Balázs C
    Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum neopterin levels in patients with Graves' disease.
    Wagner R; Hayatghebi S; Rosenkranz M; Reinwein D
    Exp Clin Endocrinol; 1993; 101(4):249-54. PubMed ID: 8307114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative hypertension during thyroidectomy for Graves' disease.
    Sharma AK; Mishra SK; Mithal A
    J Assoc Physicians India; 1995 May; 43(5):334-5. PubMed ID: 9081963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical and laboratory findings in Graves' multinodular type disease].
    Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
    Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokines levels in Graves' disease.
    Al-Humaidi MA
    Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD23 in allergic diseases.
    Rogala B; Rymarczyk B
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):251-5. PubMed ID: 10483874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease].
    Sato A; Yamada T
    Nihon Rinsho; 1999 Aug; 57(8):1904-9. PubMed ID: 10483274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T; Dembowski W; Schroth HJ; Klinger K
    Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' disease and thyroid cancer.
    Behar R; Arganini M; Wu TC; McCormick M; Straus FH; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1121-7. PubMed ID: 3787468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE.
    Inaoki M; Sato S; Takehara K
    J Dermatol Sci; 2004 Jun; 35(1):53-9. PubMed ID: 15194147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
    Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
    Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.